
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[ASND] Ascendis Pharma A/S - Time Machine
Data updated 2025-Mar-03 (Monday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
Historical Summary: 2025-Mar-03 Monday
Open | $157.78 | High | $158.00 +0.14% |
---|---|---|---|
Close | $151.93 | Low | $150.95 -4.33% |
Volume | 582 Thousand 0.86x | Volatility | 4.67% |
Change |
$-4.65
-2.97%
|
Streak | ↓ 1 days -2.97% |
20d SMA | $140.48 +8.2% | 50d SMA | $136.47 +11.3% | 100d SMA | $132.81 +14.4% | 200d SMA | $133.31 +14.0% |
RSI | 62 | MACD | 1.26 | ADX | 35.6 | Stochastic Oscillator | 90.6 89.9 |
CCI | 66.0 | ATR | 6.21 | OBV | 14.4 Million | Chaikin A/D | 23.3 Million |
Anomalies AI
Anomaly Detection for Ascendis Pharma A/S looks at key performance metrics relative to it's history (upto 10 years) for Ascendis Pharma A/S to identify unusual levels for 2025-Mar-03:
Sign Up or Login to see more performance anomalies
Anomaly Detection for Ascendis Pharma A/S looks at key technical metrics relative to it's history (upto 10 years) for Ascendis Pharma A/S to identify unusual levels for 2025-Mar-03:
Sign Up or Login to see more performance anomalies
Anomaly Details
Choose view type
Daily Performance for Ascendis Pharma A/S. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Max Chart Timespan
Max Chart Timespan
Note: Performance over Key Timeperiods for Ascendis Pharma A/S up to close of 2025-Mar-03 at $151.93
Performance Benchmarks from 2025-Mar-03 for Ascendis Pharma A/S:
Related to Ascendis Pharma A/S
Information for Ascendis Pharma A/S
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine Currently Viewing
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Mar-03 on Google
SEC Reports : Quarterly reports around 2025-Mar-03 on SEC Edgar
Compare Ascendis Pharma A/S with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ascendis Pharma A/S
Industry : Pharmaceuticals industry performance which includes Ascendis Pharma A/S